April 08, 2024 Yunkang Group Participated in S&P Global CSA for the First Time, Ranks Above 89% of Participating Global Peers March 25, 2024 Yunkang Announces 2023 Annual Results, Revenue Reaches RMB892 Million, Steps up R&D investment, Focuses on Precision Medicine and Intelligent Testing Sectors January 12, 2024 Yunkang Group Wins Three Major Awards at 7th China IR Annual Awards